Tag Archives | Sierra Leone

Rebuilding Sierra Leone’s pharmaceutical system post-Ebola

An interview with Murtada Sesay, country project director in Sierra Leone. SIAPS is working on a two-year project funded by USAID to help rebuild and strengthen the country’s pharmaceutical system following the Ebola epidemic. What’s SIAPS doing in Sierra Leone? Our systems strengthening project there was a consequence, not only of the more recent Ebola, […]

Read full story · Comments { 0 }

SIAPS launches four hospital DTCs in Sierra Leone

The USAID-funded SIAPS Program expanded its ongoing pharmaceutical sector strengthening interventions in Sierra Leone to include Drug and Therapeutics Committees (DTCs). DTCs were officially launched in the Connaught, Ola During Children’s, Makeni Government, and PCM hospitals at an event in March 2017 in Freetown. An additional 20 hospitals throughout the country are scheduled to implement […]

Read full story · Comments { 1 }

Continuous Results Monitoring and Support System Tracks Post-Ebola Recovery in Sierra Leone

The catastrophic Ebola epidemic that began in 2014 aggravated Sierra Leone’s already weak pharmaceutical supply system. The country’s pharmaceutical storage, handling, distribution, and waste disposal programs were in dire need of improvement. A “push system” of standardized medicine deliveries without reliable use data compromised inventory control and accurate forecasting, leading to frequent stock-outs or overstocks. Cost recovery also functioned poorly, potentially impacting future health care resources.

The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health (MSH), received two years of funding in September 2015 from the US Agency for International Development (USAID) to provide technical assistance for rebuilding and strengthening the post-Ebola pharmaceuti-cal supply chain management system in Sierra Leone. SIAPS helped the country institute a continuous results monitoring and support system (CRMS) to assess baseline challenges in pharmaceutical management and regularly track and support improvement in key areas. The CRMS uses a series of indicators to track and monitor factors that influence medicine availability and disease case management. Developed in Ethiopia in 2009 to bolster malaria treatment, CRMS has proven valuable in tracking performance trends so that partners and stakeholders can come together to address service gaps.

Read full story · Comments are closed

Strengthening Post-Ebola Recovery and Resiliency in Four Countries

A strong pharmaceutical management system is critical for responding to and preventing public health emergencies. The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health (MSH), is helping four countries affected by Ebola—Sierra Leone, Guinea, Mali, and Benin—recover and rebuild essential drug management and delivery services and to increase their capacity and sustainability. The two-year project began in 2015.

Read full story · Comments are closed